BABA ATSUO
No ORCID on file
· 24 papers in corpus
· active 2007-2009
Frequent coauthors
2009
The present invention provides a compound which has metastin receptor antagonist activity and is useful for preventing and treating hormone-dependent cancer, benign prostatomegaly, endometriosis, precocious puberty, uterine myoma or the lik…
2009
The present invention provides a compound which has metastin receptor antagonist activity and is useful for preventing and treating hormone-dependent cancer, benign prostatomegaly, endometriosis, precocious puberty, uterine myoma or the lik…
2009
The present invention provides a compound which has metastin receptor antagonist activity and is useful for preventing and treating hormone-dependent cancer, benign prostatomegaly, endometriosis, precocious puberty, uterine myoma or the lik…
2009
The present invention provides a compound which has metastin receptor antagonist activity and is useful for preventing and treating hormone-dependent cancer, benign prostatomegaly, endometriosis, precocious puberty, uterine myoma or the lik…
2009
The present invention provides a compound which has metastin receptor antagonist activity and is useful for preventing and treating hormone-dependent cancer, benign prostatomegaly, endometriosis, precocious puberty, uterine myoma or the lik…
2009
The present invention provides a compound which has metastin receptor antagonist activity and is useful for preventing and treating hormone-dependent cancer, benign prostatomegaly, endometriosis, precocious puberty, uterine myoma or the lik…
2009
The present invention provides a compound which has metastin receptor antagonist activity and is useful for preventing and treating hormone-dependent cancer, benign prostatomegaly, endometriosis, precocious puberty, uterine myoma or the lik…
2009
The present invention provides a compound which has metastin receptor antagonist activity and is useful for preventing and treating hormone-dependent cancer, benign prostatomegaly, endometriosis, precocious puberty, uterine myoma or the lik…
2008
The present invention provides a compound which has metastin receptor antagonist activity and is useful for preventing and treating hormone-dependent cancer, benign prostatomegaly, endometriosis, precocious puberty, uterine myoma or the lik…
2008
The present invention provides a compound which has metastin receptor antagonist activity and is useful for preventing and treating hormone-dependent cancer, benign prostatomegaly, endometriosis, precocious puberty, uterine myoma or the lik…
2008
The present invention provides a compound which has metastin receptor antagonist activity and is useful for preventing and treating hormone-dependent cancer, benign prostatomegaly, endometriosis, precocious puberty, uterine myoma or the lik…
2008
The present invention provides a compound which has metastin receptor antagonist activity and is useful for preventing and treating hormone-dependent cancer, benign prostatomegaly, endometriosis, precocious puberty, uterine myoma or the lik…
2008
The present invention provides a compound which has metastin receptor antagonist activity and is useful for preventing and treating hormone-dependent cancer, benign prostatomegaly, endometriosis, precocious puberty, uterine myoma or the lik…
2008
The present invention provides a compound which has metastin receptor antagonist activity and is useful for preventing and treating hormone-dependent cancer, benign prostatomegaly, endometriosis, precocious puberty, uterine myoma or the lik…
2008
The present invention provides a compound which has metastin receptor antagonist activity and is useful for preventing and treating hormone-dependent cancer, benign prostatomegaly, endometriosis, precocious puberty, uterine myoma or the lik…
2008
The present invention provides a compound which has metastin receptor antagonist activity and is useful for preventing and treating hormone-dependent cancer, benign prostatomegaly, endometriosis, precocious puberty, uterine myoma or the lik…
2007
Discloses is a compound which has a metastin receptor antagonistic activityand is useful for the prevention/treatment of hormone-dependent cancer, benignprostatomegaly, endometriosis, precocious puberty, hysteromyoma or the like.A compound …
2007
Discloses is a compound which has a metastin receptor antagonistic activityand is useful for the prevention/treatment of hormone-dependent cancer, benignprostatomegaly, endometriosis, precocious puberty, hysteromyoma or the like.A compound …
2007
Discloses is a compound which has a metastin receptor antagonistic activityand is useful for the prevention/treatment of hormone-dependent cancer, benignprostatomegaly, endometriosis, precocious puberty, hysteromyoma or the like.A compound …
2007
Discloses is a compound which has a metastin receptor antagonistic activityand is useful for the prevention/treatment of hormone-dependent cancer, benignprostatomegaly, endometriosis, precocious puberty, hysteromyoma or the like.A compound …
2007
Discloses is a compound which has a metastin receptor antagonistic activityand is useful for the prevention/treatment of hormone-dependent cancer, benignprostatomegaly, endometriosis, precocious puberty, hysteromyoma or the like.A compound …
2007
Discloses is a compound which has a metastin receptor antagonistic activityand is useful for the prevention/treatment of hormone-dependent cancer, benignprostatomegaly, endometriosis, precocious puberty, hysteromyoma or the like.A compound …
2007
Discloses is a compound which has a metastin receptor antagonistic activityand is useful for the prevention/treatment of hormone-dependent cancer, benignprostatomegaly, endometriosis, precocious puberty, hysteromyoma or the like.A compound …
2007
Discloses is a compound which has a metastin receptor antagonistic activityand is useful for the prevention/treatment of hormone-dependent cancer, benignprostatomegaly, endometriosis, precocious puberty, hysteromyoma or the like.A compound …